Skip to main content

Table 1 Comparisons between GBS patients with and without mechanical ventilation

From: Predictors for mechanical ventilation and short-term prognosis in patients with Guillain-Barré syndrome

Variable Group MV (n = 80) Group NV (n = 461) p value
Age (years) 43.8 ± 16.7 41.2 ± 15.3 >0.05
Male 51 (63.8 %) 280 (60.7 %) >0.05
Antecedent infections 55 (68.75 %) 301 (65.3 %) >0.05
Cranial nerve involvement 53 (66.25 %) 184 (39.91 %) <0.05
 Facial nerve 43 (81.1 %) 126 (68.5 %) <0.05
 Glossopharyngeal and vagus nerves 30 (56.6 %) 50 (27.2 %) <0.05
 Oculomotor and/or abducent nerve 12 (15 %) 57 (12.4 %) >0.05
Sensory disturbance 36 (45 %) 249 (54.0 %) >0.05
Autonomic dysfunction 7 (8.8 %) 20 (4.3 %) >0.05
Pain 7 (8.8 %) 45 (9.8 %) >0.05
Hyporeflexia or areflexia 79 (98.8 %) 434 (94.1 %) >0.05
Hospital stay (days) 38.7 ± 28.3 14.6 ± 6.3 <0.05
Treatment modality    >0.05
 IVIg 39 (48.8 %) 216 (46.9 %)  
 IVIg + intravenous corticosteroids 29 (36.2 %) 72 (15.6 %)  
 Intravenous corticosteroids 6 (7.5 %) 90 (19.5 %)  
 Supportive treatment 6 (7.5 %) 83 (18.0 %)  
  1. GBS Guillain-Barré syndrome, Group MV GBS patients with mechanical ventilation, Group NV GBS patients did not require mechanical ventilation, IVIg intravenous immunoglobulin